{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:28:30Z","timestamp":1760149710729,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>HPV has been linked to the development of precancerous and cancerous lesions. The aim of this study was to evaluate the burden of HPV-related hospitalization in Germany from 2000 to 2021 and the potential impact of the COVID-19 pandemic on it. Methods: We performed a retrospective query using data from the German Statistical Office from 2000 to 2021, including hospital admission, inpatient mortality and hospital stay length data on cervical cancer\/dysplasia, female genitourinary tract, anal, penile, head and neck cancers. Results: The HPV-attributable hospitalization rate per 100,000 inhabitants in Germany has decreased over time, from 89 cases in 2000 to 60 in 2021, with an average annual percent change (AAPC) of \u22121.93 (CI \u22122.08\u2013\u22121.79, p &lt; 0.05). The same trend was observed for the average hospital stay, which declined from 9 to 7 days, with an AAPC of \u22121.33 (CI \u22121.52\u2013\u22121.21, p &lt; 0.05). An undulating but overall slightly declining pattern was observed for the inpatient mortality (AAPC \u22120.92, CI \u22121.21\u2013\u22120.64, p &lt; 0.05). We observed a reduction in the hospitalization rates for invasive and non-invasive cervical cancer, which was observed in almost all age groups and in all German federal states. Conclusion: Our study provides a comprehensive analysis of the trends in HPV-related hospitalizations over the past two decades. The decline in hospitalization rates for cervical cancer and dysplasia suggests the potential efficacy of the HPV vaccination and screening programs.<\/jats:p>","DOI":"10.3390\/v15091857","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:42:53Z","timestamp":1693474973000},"page":"1857","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of HPV-Related Hospitalization in Germany from 2000 to 2021"],"prefix":"10.3390","volume":"15","author":[{"given":"Georgios","family":"Tampakoudis","sequence":"first","affiliation":[{"name":"Maternal-Fetal Medicine and Obstetrics Saint Luke\u2019s Hospital, 55236 Thessaloniki, Greece"},{"name":"First Department of Obstetrics and Gynaecology Papageorgiou General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-3182","authenticated-orcid":false,"given":"Olympia E.","family":"Anastasiou","sequence":"additional","affiliation":[{"name":"Institute for Virology, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"ref_1","unstructured":"IARC (2012). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100 B. A Review of Human Carcinogens: Biological Agents, IARC."},{"key":"ref_2","unstructured":"(2023, August 08). RKI, Human Papillomviren. Available online: https:\/\/www.ecdc.europa.eu\/en\/human-papillomavirus."},{"key":"ref_3","unstructured":"(2023, August 08). WHO, Human Papillomavirus (HPV). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: A synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"Plummer","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Deler\u00e9, Y., Remschmidt, C., Leuschner, J., Schuster, M., Fesenfeld, M., Schneider, A., Wichmann, O., and Kaufmann, A.M. (2014). Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: A population-based cross-sectional study via home-based self-sampling. BMC. Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-87"},{"key":"ref_8","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and Sanjos\u00e9, S. (2023, August 01). ICO\/IARC Information Centre on HPV and Cancer. Human Papillomavirus and Related Diseases in Germany. Summary Report 10 March 2023. Available online: https:\/\/hpvcentre.net\/statistics\/reports\/DEU.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deler\u00e9, Y., Meyer, C., and Reiter, S. (2007). Universal immunisation with human papillomavirus (HPV) vaccine among females aged 12\u201317 recommended in Germany. Euro. Surveill., 12.","DOI":"10.2807\/esw.12.14.03169-en"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reuschenbach, M., Mihm, S., W\u00f6lle, R., Schneider, K.M., Jacob, C., Braun, S., Greiner, W., and Hampl, M. (2020). Burden of HPV related anogenital diseases in young women in Germany\u2014An analysis of German statutory health insurance claims data from 2012 to 2017. BMC. Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05002-w"},{"key":"ref_11","unstructured":"(2023, July 12). Statistisches Bundesamt Deutschland. Available online: https:\/\/www-genesis.destatis.de\/genesis\/online."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ijc.29082","article-title":"EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection","volume":"136","author":"Giuliano","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiology. Biomark. Prev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/pubmed\/fdx025","article-title":"The burden of HPV-related diseases in Italy, 2001\u20132012","volume":"39","author":"Kuhdari","year":"2017","journal-title":"J. Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"key":"ref_16","unstructured":"(2023, June 15). Joinpoint Regression Program, Version 5.0.2\u2014May 2023; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute, Available online: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Restivo, V., Minutolo, G., Maranto, M., Maiorana, A., Vitale, F., Casuccio, A., and Amodio, E. (2023). Impact of Preventive Strategies on HPV-Related Diseases: Ten-Year Data from the Italian Hospital Admission Registry. Cancers, 15.","DOI":"10.3390\/cancers15051452"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Restivo, V., Costantino, C., Amato, L., Candiloro, S., Casuccio, A., Maranto, M., Marrella, A., Palmeri, S., Pizzo, S., and Vitale, F. (2020). Evaluation of the Burden of HPV-Related Hospitalizations as a Useful Tool to Increase Awareness: 2007\u20132017 Data from the Sicilian Hospital Discharge Records. Vaccines, 8.","DOI":"10.3390\/vaccines8010047"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Baldo, V., Cocchio, S., Buja, A., Baldovin, T., Furlan, P., Bertoncello, C., and Saia, M. (2013). Hospitalization for diseases attributable to human papillomavirus in the Veneto Region (North-East Italy). BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-462"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/21645515.2017.1412897","article-title":"Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain","volume":"14","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/hv.18388","article-title":"The burden of hospitalizations for anus and penis neoplasm in Spain (1997\u20132008)","volume":"8","author":"Ester","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/pathogens12050725","article-title":"The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015\u20132021 from a Southern Italian Region","volume":"12","author":"Cedrone","year":"2023","journal-title":"Pathogens"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e34874","DOI":"10.2196\/34874","article-title":"Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study","volume":"8","author":"Fu","year":"2022","journal-title":"JMIR Public Health Surveill."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e055470","DOI":"10.1136\/bmjopen-2021-055470","article-title":"Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: An international comparative study based on the Global Burden of Disease","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","article-title":"Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001-2017","volume":"148","author":"Damgacioglu","year":"2022","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"891623","DOI":"10.3389\/fonc.2022.891623","article-title":"Trends in Incidence, Mortality, and Survival of Penile Cancer in the United States: A Population-Based Study","volume":"12","author":"Deng","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CLEP.S330081","article-title":"Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980\u20132018)","volume":"14","author":"Piechocki","year":"2022","journal-title":"Clin. Epidemiol."},{"key":"ref_29","unstructured":"S3-Leitlinie Analkarzinom (2023, August 28). Diagnostik, Therapie und Nachsorge von Analkanal und Analrandkarzinomen. Langversion 1.2-Dezember 2020. AWMF-Registernummer: 081\/004OL. Available online: https:\/\/register.awmf.org\/assets\/guidelines\/081-004OLl_Analkarzinom_Diagnostik-Therapie-Nachsorge-Analkanalkarzinom-Analrandkarzinom_2020-12.pdf."},{"key":"ref_30","unstructured":"S3-Leitlinie Diagnostik (2023, August 28). Therapie und Nachsorge des Peniskarzinoms. Version 1.0-August 2020. AWMF-Registernummer: 043-042OL. Available online: https:\/\/register.awmf.org\/assets\/guidelines\/043-042OLl_S3_Peniskarzinom_2020-08.pdf."},{"key":"ref_31","unstructured":"Fink, D., and Ghisu, G.P. (2023, August 28). Das Screening auf Zervix-, Vulva- und Analkarzinom. Schweizer Zeitschrift f\u00fcr Gyn\u00e4kologie, 06.03.2020. Available online: https:\/\/www.rosenfluh.ch\/media\/gynaekologie\/2020\/01\/Das-Screening-auf-Zervix-Vulva-und-Analkarzinom.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Buttmann-Schweiger, N., Klug, S.J., Luyten, A., Holleczek, B., Heitz, F., du Bois, A., and Kraywinkel, K. (2015). Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999\u20132011. A population-based cancer registry analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128073"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"22551","DOI":"10.1038\/srep22551","article-title":"Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: A representative, cross-sectional, serological study","volume":"6","author":"Wilking","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0028-1119399","article-title":"Health economic effects after DRG-implementation\u2014A systematic overview","volume":"71","author":"Reinhold","year":"2009","journal-title":"Gesundheitswesen"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.vaccine.2013.03.006","article-title":"Estimating the long-term effects of HPV vaccination in Germany","volume":"31","author":"Horn","year":"2013","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","article-title":"Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors","volume":"49","author":"Vaccarella","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000525697","article-title":"Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action","volume":"45","author":"Sharma","year":"2022","journal-title":"Oncol. Res. Treat."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/9\/1857\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:44:10Z","timestamp":1760129050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/9\/1857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["v15091857"],"URL":"https:\/\/doi.org\/10.3390\/v15091857","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}